Weight-loss drug developer Metsera on Monday said it was is targeting to raise as much as $292.2 million in an initial public offering.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
Gypsy-Rose Blanchard is setting the record straight when it comes to rumors circulating about her baby daughter Aurora Raina ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...